The inhibitory effect of UVB irradiation on the expression of p53 and Ki-67 proteins in arsenic-induced Bowen's disease

Journal of Cutaneous Pathology

Volumn 24, Issue 1, 1997, Pages 8-13

  Chai, Chee Yin ^a   Yu, Hsin Su ^a   Yen, Huai Tzu ^a   Tsai, Kun Bow ^a   Chen, Gwu Shing ^a   Yu, Chia Li ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; KI 67 ANTIGEN; PROTEIN P53; STREPTAVIDIN;

ARTICLE; BOWEN DISEASE; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; SKIN BIOPSY; TIME; ULTRAVIOLET B RADIATION;

ARSENIC; BOWEN'S DISEASE; HUMANS; KI-67 ANTIGEN; MALE; STAINING AND LABELING; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET THERAPY;

EID: 0031026088     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb00779.x     Document Type: Article

References (25)

1. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 1968: 40: 453.
2. Yeh S, How SW, Lin CS. Arsenical cancer of skin - histologic study with special reference to Bowen's disease. Cancer 1968: 21: 312.
3. Lowe NJ, Prystowsky JH, Bourget T, Edelstein J, Nychay S, Armstrong R. Acitretin plus UVB therapy for psoriasis: comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol 1991: 24: 591.
4. Ramsay DL, Lish KM, Yalowitz CB, Soter NA. Ultraviolet-B phototherapy for early stage cutaneous T-cell lymphoma. Arch Dermatol 1992: 128: 931.
5. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991: 253: 49.
6. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors: an immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol 1992: 140: 145.
7. Levine AR, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991: 351: 453.
8. Szekeres G, Giacomoni PD. Ki-67 and p53 expression in cutaneous Bowen's disease: an immunohistochemical study of fixed-embedded tissue section. Acta Derm Venereol 1994: 74: 95.
9. Campbell C, Quinn AG, Angus B, Rees JL. The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Br J Dermatol 1993: 129: 235.
10. Ro YS, Cooper PN, Lee JA, et al. p53 protein expression in benign and malignant skin tumours. Br J Dermatol 1993: 128: 237.
11. Sim CS, Slater SD, McKee PH. Mutant p53 protein is expressed in Bowen's disease. Am J Dermatol 1992: 14: 195.
12. Deb S, Jackson CT, Subler MA, Martin DW. Modulation of cellular and viral promoters by mutant human p53 protein found in tumor cells. J Virol 1992: 66: 6164
13. Linden MD, Nathanson SD, Zarbo R. Evaluation of anti-p53 antibody staining: quality control and technical considerations. Appl Immunohistochem 1994: 2: 218.
14. Humphrey PA, Franquemont DW, Geary WA, Kerns BM, Iglehart JD, Marks JR. Immunodetection of p53 protein in noninvasive epithelial proliferative breast disease. Appl Immunohistochem 1994: 2: 22.
15. Takata M, Matsui Y. Proliferating cell nuclear antigen (PC-NA) and p53 protein expression in Bowen's disease. J Dermatol 1994: 21: 947.
16. Brash DE, Rudolph JA, Simon JA, et al. A role of sunlight in skin cancer. UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991: 88: 10124.
17. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK. p53 mutations in basal cell carcinomas. Cancer Res 1992: 52: 3804.
18. Hall PA, McKee PH, Menage HP, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal skin. Oncogene 1993: 8: 203.
19. Liu M, Dhanwada KR, Birt DF, Hecht S, Pelling JC. Increase in p53 protein half-life in mouse keratinocytes following UV-B irradiation. Carcinogenesis 1994: 15: 1089.
20. Maltzman W, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed cells. Mol Cell Biol 1984: 4: 1689.
21. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990: 17: 489.
22. Li JH, Rossman TG. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Molec Toxicol 1989: 2: 1.
23. Jha AN, Noditi M, Nilson R, Natarajan RT. Genotoxic effects of sodium arsenite on human cells. Mutation Res 1992: 284: 215.
24. Studniberg HM, Weller P, PUVA, UVB, psoriasis, and non-melanoma skin cancer. J Am Acad Dermatol 1993: 29: 1013.
25. Epstein JH. Photocarcinogenesis, skin cancer, and aging. J Am Acad Dermatol 1983: 9: 487.